Global Inflammatory Bowel Disease Treatment Market Is Expected to Reach $34.5 Billion by 2031: Allied Market Research
September 08, 2022 08:59 ET
|
Allied Market Research
Portland, OR, Sept. 08, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Inflammatory Bowel Disease Treatment Market generated $21.0 billion in 2021,...
Synlogic Achieves Research Milestone in Collaboration with Roche for Development of Novel Synthetic Biotic to Treat Inflammatory Bowel Disease
September 06, 2022 07:00 ET
|
Synlogic, Inc.
CAMBRIDGE, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, announced today...
First Wave BioPharma to Present at H.C. Wainwright 24th Annual Global Investment Conference 2022
August 29, 2022 07:00 ET
|
First Wave BioPharma, Inc.
BOCA RATON, Fla., Aug. 29, 2022 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
First Wave BioPharma, Inc. Announces Reverse Stock Split
August 25, 2022 12:00 ET
|
First Wave BioPharma, Inc.
BOCA RATON, Fla., Aug. 25, 2022 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the...
Colorectal Cancer Market Revenue to Cross $24.07 Bn Globally, by 2028 Growing at 3.3% CAGR - Exclusive Report by The Insight Partners
July 25, 2022 09:30 ET
|
The Insight Partners
New York, July 25, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on "Colorectal Cancer Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Modality,...
First Wave BioPharma, Inc. Announces Private Placement
July 15, 2022 08:00 ET
|
First Wave BioPharma, Inc.
BOCA RATON, Fla., July 15, 2022 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the...
Inflammatory Bowel Disease Treatment Market Size [2022-2029]: $37.00 Billion by 2029 at CAGR of 5.7%
May 30, 2022 08:10 ET
|
Fortune Business Insights
Pune, India, May 30, 2022 (GLOBE NEWSWIRE) -- The global inflammatory bowel disease treatment market size was valued at USD 23.90 billion in 2021. The market is projected to grow from USD 25.18...
Metacrine Reports First-Quarter 2022 Results
May 12, 2022 16:05 ET
|
Metacrine, Inc.
SAN DIEGO, May 12, 2022 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with gastrointestinal diseases,...
First Wave BioPharma Forms Clinical Steering Committee Focused on Advancing Inflammatory Bowel Disease (IBD) Product Portfolio
April 27, 2022 07:00 ET
|
First Wave BioPharma, Inc.
BOCA RATON, Fla., April 27, 2022 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
Global Inflammatory Bowel Disease (IBD) Drugs market is projected to grow at a CAGR of 3.77% by 2031: Visiongain Research Inc
April 19, 2022 11:00 ET
|
Visiongain Ltd
Visiongain has published a new report on Inflammatory Bowel Disease Drugs Market Report 2021-2031. Profiles of Inflammatory Bowel Disease Drugs and Forecasts by Drug Class (Biologics,...